Cited 42 times in

MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line

DC Field Value Language
dc.contributor.author김상운-
dc.contributor.author김성훈-
dc.contributor.author김영태-
dc.contributor.author김재훈-
dc.contributor.author남은지-
dc.contributor.author이마리아-
dc.contributor.author임가원-
dc.date.accessioned2014-12-19T16:34:34Z-
dc.date.available2014-12-19T16:34:34Z-
dc.date.issued2012-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/89789-
dc.description.abstractBACKGROUND: Cancer stem cells (CSCs) are thought to be a source of tumor recurrence due to their stem cell-like properties. MicroRNAs (miRNAs) regulate both normal stem cells and CSCs, and dysregulation of miRNAs has an important role in tumorigenesis. Cluster of differentiation (CD) 133(+) and spheroid formation have been reported to be one of the main features of ovarian CSCs. Therefore, we determined the miRNA expression profile of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line. METHODS: Initially, we confirmed the enrichment of the OVCAR3 CD133 subpopulation by evaluating in vitro anchorage-independent growth. After obtaining a subpopulation of CD133(+) OVCAR3 cells with > 98% purity via cell sorting, miRNA microarray and real-time reverse transcription-polymerase chain reaction (RT-PCR) were performed to evaluate its miRNA profile. RESULTS: We found 37 differentially expressed miRNAs in the CD133(+) spheroid-forming subpopulation of OVCAR3 cells, 34 of which were significantly up-regulated, including miR-205, miR-146a, miR-200a, miR-200b, and miR-3, and 3 of which were significantly down-regulated, including miR-1202 and miR-1181. CONCLUSIONS: Our results indicate that dysregulation of miRNA may play a role in the stem cell-like properties of ovarian CSCs.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.relation.isPartOfBMC MEDICAL GENOMICS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAC133 Antigen-
dc.subject.MESHAntigens, CD/metabolism*-
dc.subject.MESHBlotting, Western-
dc.subject.MESHCell Proliferation/drug effects-
dc.subject.MESHCluster Analysis-
dc.subject.MESHDrug Resistance, Neoplasm/drug effects-
dc.subject.MESHDrug Resistance, Neoplasm/genetics-
dc.subject.MESHFemale-
dc.subject.MESHFlow Cytometry-
dc.subject.MESHGene Expression Profiling-
dc.subject.MESHGene Expression Regulation, Neoplastic-
dc.subject.MESHGlycoproteins/metabolism*-
dc.subject.MESHHumans-
dc.subject.MESHMicroRNAs/genetics*-
dc.subject.MESHMicroRNAs/metabolism-
dc.subject.MESHNeoplastic Stem Cells/drug effects-
dc.subject.MESHNeoplastic Stem Cells/metabolism-
dc.subject.MESHNeoplastic Stem Cells/pathology-
dc.subject.MESHOligonucleotide Array Sequence Analysis-
dc.subject.MESHOvarian Neoplasms/genetics*-
dc.subject.MESHOvarian Neoplasms/pathology*-
dc.subject.MESHPaclitaxel/pharmacology-
dc.subject.MESHPeptides/metabolism*-
dc.subject.MESHReproducibility of Results-
dc.subject.MESHReverse Transcriptase Polymerase Chain Reaction-
dc.subject.MESHSpheroids, Cellular/drug effects-
dc.subject.MESHSpheroids, Cellular/metabolism*-
dc.subject.MESHSpheroids, Cellular/pathology*-
dc.subject.MESHTumor Cells, Cultured-
dc.titleMicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Obstetrics & Gynecology (산부인과학)-
dc.contributor.googleauthorEun Ji Nam-
dc.contributor.googleauthorMaria Lee-
dc.contributor.googleauthorGa Won Yim-
dc.contributor.googleauthorJae Hoon Kim-
dc.contributor.googleauthorSunghoon Kim-
dc.contributor.googleauthorSang Wun Kim-
dc.contributor.googleauthorYoung Tae Kim-
dc.identifier.doi10.1186/1755-8794-5-18-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00595-
dc.contributor.localIdA00526-
dc.contributor.localIdA00729-
dc.contributor.localIdA00876-
dc.contributor.localIdA01262-
dc.contributor.localIdA02748-
dc.contributor.localIdA03354-
dc.relation.journalcodeJ00362-
dc.identifier.eissn1755-8794-
dc.identifier.pmid22643117-
dc.subject.keywordMicroRNA-
dc.subject.keywordCancer stem cell-
dc.subject.keywordOvarian cancer-
dc.subject.keywordCD133-
dc.subject.keywordOVCAR3-
dc.subject.keywordChemoresistance-
dc.contributor.alternativeNameKim, Sang Wun-
dc.contributor.alternativeNameKim, Sung Hoon-
dc.contributor.alternativeNameKim, Young Tae-
dc.contributor.alternativeNameKim, Jae Hoon-
dc.contributor.alternativeNameNam, Eun Ji-
dc.contributor.alternativeNameLee, Maria-
dc.contributor.alternativeNameYim, Ga Won-
dc.contributor.affiliatedAuthorKim, Sung Hoon-
dc.contributor.affiliatedAuthorKim, Sang Wun-
dc.contributor.affiliatedAuthorKim, Young Tae-
dc.contributor.affiliatedAuthorKim, Jae Hoon-
dc.contributor.affiliatedAuthorNam, Eun Ji-
dc.contributor.affiliatedAuthorLee, Maria-
dc.contributor.affiliatedAuthorYim, Ga Won-
dc.citation.volume5-
dc.citation.startPage18-
dc.identifier.bibliographicCitationBMC MEDICAL GENOMICS, Vol.5 : 18, 2012-
dc.identifier.rimsid31905-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.